Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.55B |
| 2 |
Gilead Sciences
GILD
|
+$968M |
| 3 |
CME Group
CME
|
+$953M |
| 4 |
Broadcom
AVGO
|
+$809M |
| 5 |
TE Connectivity
TEL
|
+$753M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$2.6B |
| 2 |
CSX Corp
CSX
|
+$2.44B |
| 3 |
Amgen
AMGN
|
+$2.27B |
| 4 |
AbbVie
ABBV
|
+$1.67B |
| 5 |
Netflix
NFLX
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.59% |
| 2 | Technology | 15.06% |
| 3 | Communication Services | 14.47% |
| 4 | Consumer Discretionary | 13.12% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Las Vegas Sands
LVS
$29.5B
| $731M | 0.21% |
12,322,121
-1,082,048
| -8% | -$72.6M |
|
|
102
TE Connectivity
TEL
$62.2B
| $720M | 0.21% |
+8,189,669
| New | +$753M |
|
103
Melco Resorts & Entertainment
MLCO
$2.14B
| $715M | 0.21% |
33,785,801
+15,930,285
| +89% | +$370M |
|
104
Old Dominion Freight Line
ODFL
$44.7B
| $694M | 0.2% |
12,904,269
-7,803,075
| -38% | -$395M |
|
105
Herbalife
HLF
$1.25B
| $687M | 0.2% |
12,586,272
-3,654,486
| -23% | -$202M |
|
106
PNC Financial Services
PNC
$102B
| $683M | 0.2% |
5,014,567
-8,188,735
| -62% | -$1.16B |
|
107
Cigna
CI
$73.8B
| $682M | 0.2% |
+3,275,920
| New | +$607M |
|
108
Starbucks
SBUX
$125B
| $681M | 0.2% |
11,979,674
-4,242,780
| -26% | -$224M |
|
109
Visa
V
$676B
| $677M | 0.2% |
4,507,351
+4,395,051
| +3,914% | +$625M |
|
|
FRC
110
DELISTED
First Republic Bank
FRC
| $675M | 0.2% |
+7,032,359
| New | +$708M |
|
111
Integra LifeSciences
IART
$1.43B
| $671M | 0.2% |
10,186,218
+423,324
| +4% | +$26.3M |
|
112
Western Union
WU
$2.26B
| $670M | 0.19% |
35,154,911
-12,223,387
| -26% | -$237M |
|
113
UBS Group
UBS
$177B
| $663M | 0.19% |
41,965,819
-28,171,894
| -40% | -$443M |
|
114
Medtronic
MDT
$116B
| $656M | 0.19% |
6,672,591
-6,739,153
| -50% | -$623M |
|
115
Atlassian
TEAM
$39.7B
| $639M | 0.19% |
+6,645,453
| New | +$526M |
|
116
Nutrien
NTR
$32B
| $639M | 0.19% |
11,071,489
-1,367,125
| -11% | -$75.7M |
|
117
Edwards Lifesciences
EW
$53.4B
| $617M | 0.18% |
10,635,798
+6,619,617
| +165% | +$324M |
|
|
HOLX
118
DELISTED
Hologic
HOLX
| $614M | 0.18% |
14,972,736
-3,587,628
| -19% | -$145M |
|
119
Cummins
CMI
$87B
| $609M | 0.18% |
4,165,976
-2,487
| -0.1% | -$350K |
|
120
Trimble
TRMB
$13B
| $606M | 0.18% |
13,935,494
-2,029,529
| -13% | -$79.3M |
|
121
Caterpillar
CAT
$391B
| $600M | 0.17% |
3,934,537
+2,924,169
| +289% | +$414M |
|
122
TransDigm Group
TDG
$67.4B
| $597M | 0.17% |
1,604,176
-285,733
| -15% | -$103M |
|
123
Target
TGT
$70.6B
| $591M | 0.17% |
6,704,900
-3,227,557
| -32% | -$268M |
|
124
Stanley Black & Decker
SWK
$15.5B
| $589M | 0.17% |
+4,023,856
| New | +$573M |
|
|
GWPH
125
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $583M | 0.17% |
3,375,580
-144
| -0% | -$20.8K |
|
Similar funds
Capital Research Global Investors's Q3 2018 Portfolio in Review
As of Q3 2018, Capital Research Global Investors held 485 positions worth $344B, down 6% from $366B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors withdrew a net $39.8B in Q3 2018, closing 49 positions and reducing 220 holdings. Its most notable exit was Praxair Inc, an estimated $1.17B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Capital Research Global Investors opened a new position in TE Connectivity worth $720M.
- Capital Research Global Investors's largest Q3 2018 buy was TE Connectivity: 8,189,669 shares worth $720M.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q3 2018, an estimated $4.55B increase.
- Capital Research Global Investors's biggest Q3 2018 reduction was Wells Fargo, cutting an estimated $2.6B.
- Capital Research Global Investors fully exited Praxair Inc in Q3 2018, selling an estimated $1.17B.
- Capital Research Global Investors's ten largest holdings make up 29% of its $344B portfolio in Q3 2018.
- Capital Research Global Investors opened 45 new positions and closed 49 in Q3 2018.
- Capital Research Global Investors's portfolio value fell 6% quarter-over-quarter to $344B.
Based on Capital Research Global Investors's 13F filing for Q3 2018, filed 14 Nov 2018.